Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Epizyme Inc. (EPZM)

11.51   -0.42 (-3.52%) 10-01 16:12
Open: 12 Pre. Close: 11.93
High: 12.1 Low: 11.3
Volume: 974,513 Market Cap: 1,168M
Epizyme, Inc. is a clinical-stage biopharmaceutical company. The company is headquartered in Cambridge, Massachusetts and currently employs 124 full-time employees. The firm discovers, develops and plans to commercialize epigenetic therapies for cancer patients. The firm is engaged in the discovery and development of novel epigenetic therapies for cancer patients. The firm develops small molecule inhibitors of a class of enzymes known as histone methyltransferases (HMTs). The firm develops small molecule inhibitors of other chromatin modifying proteins (CMPs). The firm's lead product candidate, tazemetostat, is a potent and selective inhibitor of the enhancer of zeste homolog 2 (EZH2) histone methyltransferases (HMT), an enzyme that plays an important role in various cancers. The firm is evaluating tazemetostat in a Phase II study in adults with relapsed or refractory non-Hodgkin lymphoma (NHL), and one Phase I study in children with molecularly defined solid tumors. The firm owns the global development and commercialization rights to tazemetostat outside of Japan.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 12.205 - 12.287 12.287 - 12.355
Low: 11.615 - 11.694 11.694 - 11.759
Close: 11.813 - 11.943 11.943 - 12.05

Technical analysis

as of: 2020-10-01 3:33:07 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 14.85     One year: 15.87
Support: Support1: 11.30    Support2: 9.40
Resistance: Resistance1: 12.72    Resistance2: 13.59
Pivot: 12.36
Moving Average: MA(5): 11.90     MA(20): 12.42
MA(100): 14.94     MA(250): 16.83
MACD: MACD(12,26): -0.32     Signal(9): -0.25
Stochastic oscillator: %K(14,3): 17.05     %D(3): 22.82
RSI: RSI(14): 36.92
52-week: High: 27.82  Low: 9.74  Change(%): 5.1
Average Vol(K): 3-Month: 93069  10-Days: 100405

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
EPZM has closed above bottom band by 7.0%. Bollinger Bands are 19.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sat, 26 Sep 2020
Epizyme, Inc. (EPZM) climbs 1.79%, marking win over bears - Marketing Sentinel

Wed, 23 Sep 2020
Epizyme Inc. (EPZM) Plunges 5.69% on September 23 -

Wed, 23 Sep 2020
Epizyme Inc. (EPZM) recent quarterly performance of -30.93% is not showing the real picture - News Daemon

Wed, 23 Sep 2020
Highlights from the Ratings and Financial Report for Epizyme Inc. (EPZM) - The News Heater

Tue, 22 Sep 2020
Epizyme Inc (NASDAQ:EPZM) Expected to Announce Quarterly Sales of $7.97 Million - MarketBeat

Mon, 21 Sep 2020
Is Epizyme Inc (EPZM) Stock a Good Value Monday? - InvestorsObserver

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 101
Shares Float (M) 83
% Held by Insiders 4.04
% Held by Institutions 100.97
Shares Short (K) 9,660
Shares Short P. Month (K) 11,000

Stock Financials

EPS -2.000
EPS Est This Year -2.360
EPS Est Next Year -2.440
Book Value (p.s.) 2.540
Profit Margin
Operating Margin -1477.56
Return on Assets (ttm) -32.0
Return on Equity (ttm) -65.2
Qtrly Rev. Growth -58.2
Gross Profit (p.s.) -1.073
Sales Per Share 0.136
EBITDA (p.s.) -1.996
Qtrly Earnings Growth
Operating Cash Flow (M) -184
Levered Free Cash Flow (M) -163

Stock Valuations

PE Ratio -5.72
PEG Ratio
Price to Book value 4.50
Price to Sales 83.87
Price to Cash Flow -6.29

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.